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ABSTRACT
THE ROLE OF PROTEIN KINASE A IN HYPOXIA-INDUCED
PC-12 CELL DEATH
Cynthia Jayne Miller
July 1, 2008

Hypoxia is characterized by an inadequate oxygen supply to the tissues in
proportion to their metabolic needs, and is a primary factor in traumatic CNS
injury, strokes, cardiopulmonary diseases, and obstructive sleep apnea. The
cAMP-dependent protein kinase (PKA) has been attributed a role as an antiapoptotic kinase as well as a pro-apoptotic signal. Thus the role of PKA in
hypoxia-induced cell survival is currently unclear.
We show here that hypoxia induces cell death in WT PC-12 cells,
pheochromocytoma cells used as a model of the oxygen-sensitive carotid body
glomus cells. The onset of cell death following 24 hours of severe, sustained
hypoxia also correlated with an increase in oxidative stress and a drop in ATP
levels. Inactivation of PKA in the 123.7 PC-12 cell line prevented the hypoxiainduced ROS surge, energy depletion, and cell death. PKA activity thus
contributes to hypoxia~induced cell death in WT cells via enhanced ROS
production and energy depletion, but was not shown to playa role in the
regulation of cellular antioxidant mechanisms.

iv

123.7 cells had lower levels of hypoxia-induced glucose utilization and
lactate release than WT cells, thus PKA appears to stimulate increases in
glycolytic flux during hypoxia.

Mitochondrial potentials were higher in 123.7

cells than in WT cells, indicating that PKA inhibits mitochondrial metabolism.
Furthermore, the expression of COX IV was decreased by hypoxic exposure in
both cell types, but was significantly greater in 123.7 cells. The greater
expression of COX IV may allow 123.7 cells to maintain mitochondrial electron
flow and energy production under drastically reduced oxygen conditions.
Antioxidant treatment blocked hypoxia-induced cell death, but was not
sufficient to prevent depletion of ATP or to modulate the metabolic pathways.
Thus, this finding indicates that hypoxia-induced metabolic regulation and energy
depletion occur independently of oxidative stress.
Consequently, the PKA signaling pathway appears to contribute to
hypoxia-induced cell death through its regulatory effects on oxidative stress and
metabolic pathways. Modulation of the PKA signaling pathway could provide
novel therapeutic strategies to improve cellular adaptation and recovery in the
many pathologies characterized by periods of hypoxia.
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INTRODUCTION

Hypoxia is characterized by an inadequate oxygen supply to the tissues
in proportion to their metabolic need and can result from a number of conditions
that cause defective oxygen uptake at the lungs, or insufficient transport of
oxygen-rich blood to the tissues. Hypoxia is a primary factor in traumatic eNS
injury, strokes, cardiopulmonary diseases, and obstructive sleep apnea (OSA).
Strokes, resulting from severe hypoxic events, are among the most prevalent
causes of death nationwide, (1) while OSA affects 2-5% of the population in the
United States (2).
It has been previously reported that hypoxia induces apoptosis and that
the extent of the apoptotic response is critically dependent on the severity and
the duration of the hypoxic injury (3). Hypoxia induces gene transcription by
cooperative activation of several transcription factors, notably NF-KB, AP-1 and
the hypoxia-inducible HIF-1a (4,5,6,7). Thus, an understanding of the
mechanisms underlying cellular survival to hypoxia may provide novel therapies
to improve cellular outcome of hypoxia/ischemia and some neurodegenerative
pathologies.
When cells are exposed to hypoxia, there is a shift in cellular metabolism
(Figure 1) from aerobic, mitochondrial energy production to anaerobic glycolytic
1

processes. In the process of glycolysis, cells harness the energy of the
carbohydrate glucose in a series of cytoplasmic enzymatic reactions, resulting in
a net production of two pyruvate, two ATP, and two NADH molecules. In the
presence of oxygen, pyruvate is converted in a transition reaction to acetyl CoA,
producing two additional molecules of NADH. Acetyl CoA then enters a series of
enzymatic reactions in the mitochondria known as the Krebs Cycle, resulting in
the production of 6 NADH and 2 FADH 2 .
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Figure 1: Mitochondrial Metabolism. Under normoxic conditions ,
energy is produced via both glycolysis and aerobic, mitochondrial
pathways. However, under hypoxic states, aerobic metabolism is
decreased and cells must rely on glycolysis for energy production_

2

Cytoplasmic NADH from glycolysis can be transported in the mitochondria
using either the glycerophosphate shuttle or the malate-aspartate shuttle,
producing FADH2 or NADH, respectively, on the matrix side of the inner
mitochondrial membrane. The reduced compounds derived from glycolysis and
the Krebs Cycle then donate electrons to a series of redox carriers in the
mitochondria known as the electron transport chain. At complex IV, cytochrome
oxidase, the electrons are used to reduce 02 to H20.
The movement of electrons through the chain to more positive redox
potentials results in the formation of energy, harnessed in the form of a proton
gradient. The movement of protons back down their electrochemical gradient
across the inner mitochondrial membrane is used to produce ATP via the
enzyme ATP synthase. Under aerobic conditions, one molecule of glucose can
produce 36-38 ATP, depending on the NADH shuttle system utilized.
However, during hypoxia, oxygen-dependent oxidative phosphorylation
processes decline and cells must progressively rely on anaerobic metabolism.
Hypoxia has been shown in PC-12 cells to decrease the activity of enzymes
involved in oxidative phosphorylation, including Complexes I, II, and IV of the
electron transport chain (8). Furthermore, hypoxic upregulation of glycolytic
enzymes, such as hexokinase and phosphofructokinase, has been shown in PC12 cells (8). This decreased oxidative phosphorylation can present a significant
problem in energy homeostasis, since glycolysis produces a net gain of only 2
ATP relative to the approximately 38 ATP that can be produced by oxidative
phosphorylation and glycolytic processes combined.
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Mitochondria contain a large number of redox carriers, such as those of
the mitochondrial electron transport chain, that are capable of leaking electrons.
Under physiological cellular conditions, some of these electrons slip away from
their oxidative pathways to oxygen and produce superoxide anion, a progenitor
reactive oxygen species (ROS). In resting cells, approximately 1-2% of the
electrons passing through the electron transport chain undergo this process,
resulting in a significant basal production of ROS (9). It is believed that
Complexes I and III of the electron transport chain are the primary sites of
superoxide production (10). Mitochondria are thus particularly susceptible to
oxidative injury due to their constant generation and close proximity to the shortlived ROS. Furthermore, mitochondrial DNA is prone to oxidative injury because
it lacks the protection of histone proteins, and mitochondrial DNA polymerases
are highly susceptible to ROS damage (11).
While a certain basal level of ROS appear to be required for proper cell
function (12), dysregulation may result in overproduction of superoxide anion and
increased formation of toxic ROS. Consequently, cells have elaborate defense
systems in place to counteract the production of ROS. It is only once these
defense systems become overwhelmed that oxidative stress ensues.
Many primary defense mechanisms exist to neutralize reactive oxygen
species before they inflict damage on cellular structures. These include enzymes
such as superoxide dismutase, catalase, and glutathione peroxidase.
Superoxide dismutase (SOD) catalyzes the conversion of the superoxide free
radical into another ROS, hydrogen peroxide. Hydrogen peroxide can then be
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converted to water and oxygen by the enzymes catalase or glutathione
peroxidase. Catalase, which is present only in
peroxisomes, is a highly efficient, unsaturable enzyme
under physiological conditions. The tripeptide glutathione
(y-Glu-Cys-Gly), which is present in both the cytosol and

H20 2

H20

~
Glutathione Peroxidase

~
GSSG
~
GSH

mitochondria, makes up one of the main cellular
antioxidant defenses and detoxification pathways (Figure
2).

Gluthathione Reductase

~

NADP+ NADPH
In an unstressed cell, glutathione

redox balance is achieved by the
maintenance of the GSH (reduced)/GSSG
(oxidized) glutathione ratio. This balance is

Figure 2: Glutathione Redox
Cycle. The reduced form of
glutathione (GSH) detoxifies
hydrogen peroxide. NADPH is
used to regenerate GSH from
its oxidized form.

tightly regulated by the availability of NADPH, which is required to regenerate
GSH from its oxidized GSSG form in the glutathione redox cycle. Upon oxidant
stress, GSH will react with ROS and GSSG will increase, decreasing the
GSH/GSSG ratio. Therefore, measurements of cellular GSH/GSSG and NADPH

can be used as indicators of cellular redox status.
Low oxygen availability may perturb the mitochondrial electron transfer
chain, resulting in increased ROS and disruption of cellular energy balance (13).
In cardiomyocytes and hepatocytes, hypoxia decreases Vmax of the rate limiting,
oxygen-dependent enzyme of the mitochondrial respiratory chain, cytochrome
oxidase (COX IV) (14,15). COX IV is the terminal electron acceptor in the
mitochondrial electron transport chain which converts molecular oxygen (0 2 ) to
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water. COX IV consists of 13 subunits, 3 of which (subunits I, II, and II) are
encoded by mitochondrial DNA and synthesized directly in the mitochondria (8).
The other 10 subunits of cytochrome oxidase (IV, Vb, Via, Vlb, Vic, VilA, Vllb,
and VIII) are synthesized in the cytosol by the nuclear genome, and then
transported into the mitochondria (8).
Hypoxia has been shown to decrease the activity of COX IV in rat
macrophages and PC-12 cells (8). This drop in activity of the terminal electron
complex could produce
a "trafficking" problem

Sustained Hypoxia

through the electron
transport chain,
resulting in an
increased slippage of
electrons away from
-0 2

their normal movement

-02

Figure 3: Effect of Hypoxia on Reactive
Oxygen Species Generation in the Electron
Transport Chain. Hypoxia decreases the
activity of Complex 4 of the mitochondrial
electron transport chain, leading to an increased
production of superoxide anion, a progenitor
reactive oxygen species.

through the chain, and
increased production of
ROS (Figure 3). This
process could potentially
overwhelm the antioxidant

capabilities of the cell, leading to oxidative stress, and cellular death.
Protein Kinase A (PKA) signaling may affect multiple mitochondrial chain
enzymes. PKA has been shown in mouse fibroblasts to directly phosphorylate
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an 18kDA subunit of complex I of the mitochondrial electron transport chain,
resulting in an increase in its activity (16). Furthermore, PKA has been shown to
phosphorylate subunits I, IV, and Vb of complex IV of the mitochondrial electron
transport chain. In vitro phosphorylation of COX IV by PKA in bovine heart and
rat macro phages decreases its activity by 40-70% (17). Furthermore, the Ria
regulatory subunit of PKA directly binds to the Vb subunit of COX IV and inhibits
its activity (18). All of these PKA-mediated effects could potentially increase the
leakage of electrons away from the mitochondrial electron transport chain , and
shift the redox balance of the cell towards a state of oxidative stress. Indeed, it
has been shown in rat macrophages that PKA phosphorylation of COX IV under
hypoxic conditions leads to a

•••
. ---..
cAMP

o ./ "'-.
Active

decrease in COX IV activity and

Regulatory
Subunits
Catalytic
Subunits

generation of excess ROS (17).
Furthermore, in the rabbit heart,
inhibitors of PKA were shown to
have protective effects against

O

ischemia-reperfusion injury (17).
The ubiquitously

Figure 4: Protein Kinase A Activation.
cAMP binds to the regulatory subunits of
PKA, inducing a conformation change
that allows the catalytic subunits to
dissociate and phosphorylate PKA
substrates.

expressed cAMP-dependent
protein kinase (PKA) is a
tetramer consisting of two

regulatory subunits and two catalytic subunits (Figure 4) (19). Upon stimulation,
cAMP is increased and binds to the regulatory subunits, inducing the release of
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the catalytic subunits to phosphorylate PKA substrates. Intracellular cAMP levels
are maintained through a G-protein signaling cascade regulating the enzyme
adenylate cyclase. The binding of an extracellular ligand to a G-protein coupled
receptor facilitates the dissociation of the heterotrimeric G-protein. Upon
stimulation, the a-subunit binds GTP and dissociates from the

~-y

subunit. The

activated a-subunit is then able to modulate the activity of adenylate cyclase.
Activation of the stimulatory G protein cascade (G s ) increases adenylate
cyclase activity and cAMP production, while stimulation of the inhibitory G protein
(G i ) inhibits adenylate cyclase and decreases cAMP levels. Under basal
conditions, cAMP concentrations are kept at a low level of around 10-7 M (19).
However, upon stimulation cAMP levels can rise over twenty fold (19). cAMP
levels are thus carefully regulated in cells through an intricate process of
formation by adenylate cyclase and degradation via cAMP phosphodiesterase.
Activity of cAMP phosphodiesterase is essential for the maintenance of localized
cAMP gradients and compartmentalization of PKA signaling (20,21).
cAMP binds to PKA in a positive cooperative manner, allowing the
dissociation of the catalytic subunits to phosphorylate intracellular substrates.
One of the most studied PKA cellular targets is the ubiquitously expressed
transcription factor, cAMP response element binding protein (CREB). PKA
phosphorylates CREB at a single serine residue (22), resulting in its activation.
CREB then recruits a transcriptional activator, the CREB binding protein (CBP),
and binds to the cAMP response element (CRE) producing alteration in gene
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expression. Therefore, PKA is essential to the transcriptional control of a wide
variety of CREB-driven genes.
Although several isofonns of PKA have been identified, two main types of
PKA (PKA I and II) have been described, differing in their regulatory subunit (RI
and RII), and their relative sensitivity to cAMP levels. RI contains a high affinity
binding site for Mg-ATP, while RII contains an auto-phosphorylation site (23,24).
PKA I responds to small, transient alterations in cAMP levels, while PKA II is
activated by sustained, high cAMP levels (25). It was originally thought that PKA
I was a cytosolic protein, while PKA II was tethered to specific intracellular
locations via the A Kinase Anchoring Proteins (AKAPs). However, recent
evidence identified AKAPs that bind to both isofonns, as well as AKAPs that are
specific for PKA I (26). AKAPs bind PKA to specific intracellular membranes,
organelles, or cytoskeletal components, allowing for localization of PKA close to
its upstream activators and downstream phosphorylation targets.
PKA activity is also controlled by endogenous protein kinase inhibitor
peptides (PKls). These heat stable peptides bind to the free catalytiC subunit of
PKA and inhibit its activity (27). PKls also transports the free catalytiC subunit
from the nucleus into the cytoplasm, thus diminishing its effects on gene
transcription (27).
PKA regulates a wide variety of cellular processes including cert cycle and
growth, ion fluxes, microtubule dynamics, chromatin condensation, and nuclear
envelope fonnation (26). It has been attributed a role as an anti-apoptotic kinase
as well as a pro-apoptotic signal, thus the role of PKA in hypoxia-induced cell
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survival is currently unclear (28,29). It is widely accepted that PKA
phosphorylates and inhibits the pro-apoptotic protein BAD, and has thus been
classically defined as an anti-apoptotic kinase. Furthermore, PKA has also been
shown to bind to the pro-apoptotic p73, phosphorylating and inhibiting the activity
of this p53 tumor suppressor homolog (30). Activation of PKA has been shown
to be neuroprotective in a variety of neuronal models (31). This protection may
be due to PKA phosphorylation and activation of CREB pathways, suppression of
neuronal Nitric Oxide Synthase (nNOS), and/or inhibition of the IP3 receptor and
the subsequent drop in calcium release from the endoplasmic reticulum
(32,33,34 ).
More recent work suggests that PKA has numerous pro-apoptotic roles in
the hypoxic response. Consequently, the role of PKA in hypoxia-induced cell
death may be critically dependent on the severity and duration of the insult. In
addition to its role in electron transport chain regulation, PKA has been
implicated in the control of the glycolytic rate limiting enzyme,
phosphofructokinase, implicating PKA in the regulation of glucose metabolism
(35,36). PKA-dependent transcription factors are also required for the hypoxiainducible factor, HIF-1 a transcriptional activity, necessary for up-regulation of
glycolytic enzymes and glucose transporters (6,37,38).
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HIF-1 is a heterodimeric protein consisting of a. and ~ subunits (Figure 5).
While both subunits are constitutively expressed, HIF-1a. undergoes continuous
Normoxia
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Adapted from Zagor.;l<a A. Dulak J . HIF-1 : the knowns
and unknowns of hypoxia sensing .
Acta Biochim Pol.
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Figure 5: Regulation of the Hypoxia Inducible Factor 1
(HIF-1) under Normoxic and Hypoxic Conditions.
HIF-1a. is constitutively expressed, but under normoxic
conditions is hydroxylated and degraded by the
proteosome. Under hypoxic conditions, hydroxylation of
HIF-1 a. is inhibited and the protein is able to translocate to
the nucleus and associate with HIF-1~. The dimer then
binds the Hypoxia Response Element (HRE) and initiates
gene transcription.
degradation during normoxic conditions. When oxygen is abundant, HIF-1 a. is
hydroxylated at Pr0402 and Pro564 by HIF-1 prolyl-4 hydroxylases, targeting the
protein for degradation. von Hippel-Lindau tumor suppressor proteins (pVHLs)
bind to the hydroxylated protein residues, and subsequently attract other
members of the E3 ubiquitin ligase complex. HIF-1 a. is then ubiquitinated and
degraded by the 265 proteasome. Under hypoxic conditions, the HIF-1 prolyl
11

hydroxylases are inactivated through largely unknown mechanisms, and HIF-1a
is able to escape hydroxylation, ubiquitination, and subsequent degradation.
The activation of HIF-1a is also regulated by oxygen availability. Under
normoxic conditions, an Asn803 residue within the C-terminal transactivation
domain is hydroxylated by the factor inhibiting HIF-1 (FIH-1), and the binding of
essential coactivators is prevented (39). This hydroxylation is inhibited under
hypoxic conditions, thus allowing transcriptional activation to proceed. However,
in order for transcription to occur, HIF-1 a must first translocate to the nucleus,
where it is able to dimerize with the HIF-1J3 subunit. HIF-1 then binds to the
hypoxia response element (HRE), allowing the regulation of processes integral to
oxygen homeostasis.
While HIF-1a regulates adaptive genes involved in erythropoiesis,
angiogenesis, glucose and energy metabolism, recent reports also implicate HIF1a in hypoxia-induced cell death after prolonged and severe hypoxia via p53 or
pro-apoptotic Bcl2-family members-dependent mechanisms (40,41,42).
Hypoxia-induced ROS, which is believed to be increased by PKA activity, may
also further activate HIF-1 a, enhancing the cell's transcriptional response to
hypoxia (43). Consequently, the PKA pathway may have an important role in the
regulation of metabolic pathways and energy production.
The rat PC-12 cell line has been widely used as a model of oxygen
sensitive, neuronal-like cells to study hypoxia-induced signaling (44,45,46). PC12 cells closely resemble carotid body type I cells, or glomus cells,
morphologically and phenotypically (44). Both cell types are excitable, oxygen12

sensitive, and resistant to hypoxia-induced cell death (46). Carotid body glomus
cells increase their firing rate in response to hypoxia, hypercapnia, and/or
acidosis. This signal is transmitted via the glossopharyngeal nerve to the dorsal
respiratory group of the medulla, which stimulates ventilation.
In PC-12 cells, exposure to hypoxia causes inactivation of an oxygensensitive potassium channel (Shaker KV1.2 K+ channel) leading to a graded
depolarization of the cell membrane (46). This depolarization opens voltage
gated calcium channels, producing an influx of calcium into the cell. The
increase in intracellular calcium leads to a variety of effects, including the
synthesis and release of neurotransmitters such as dopamine, adenosine, and
glutamine, and alterations in gene expression (46). Intracellular calcium binds to
calmodulin, leading to activation of a variety of enzymes, including calmodulin
kinases and Ca2+ regulated adenylate cyclases. Thus, there is a direct link
between hypoxia-induced responses and PKA signaling in PC-12 cells.
In order to examine the effects of PKA activity on hypoxic cell death, I
used a genetically altered line of PC-12 cells, called 123.7 cells, which have a
mutated PKA I regulatory subunit. This mutation prevents the binding of cAMP,
such that the catalytic subunits of PKA can not be released, and only minimal
PKA activity exists (47). Upon stimulation with 5 fJM of cAMP, 123.7 cells
displayed only 12% PKA I activity and 16% PKA II activity (47). This suggests
that RI and RII compete for the same pool of catalytic subunits (47). cAMP is
unable to bind to RI, preventing the dissociation of the catalytic subunits from the
mutant PKA I tetramer. PKA I sequesters the catalytic subunits, and prevents
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their binding to the non-mutated RII subunits. In this manner, mutation of one
isoform drastically reduces the activity levels of both PKA I and II. The use of the
123.7 cell line allows elucidation of the contribution of the PKA pathway to
cellular energy homeostasis and hypoxia-induced oxidative stress.
Based on the current literature, I hypothesized that PKA activity regulates
PC-12 hypoxic cell death via oxidative stress and cellular energy depletion. To
examine this hypothesis, Specific Aim 1 was to determine whether PKA activity
affects cellular tolerance to hypoxia and production of oxidant species. WT and
123.7 PC-12 cells were exposed to either normoxic or sustained hypoxic
conditions for up to 24h. Cellular viability was assessed in each cell line to
determine (1) whether hypoxia induced cell death in the PC-12 cell line and (2)
whether PKA activity, which is present in the WT cell line but minimal in the 123.7
cell line, contributed to this hypoxia-induced cell death. ROS levels were also
analyzed in WT and 123.7 cells to examine the role of hypoxia and/or PKA
activity in cellular oxidative stress. However, ROS levels are not only dependent
on their rate of production, but also on their rate of detoxification by antioxidant
systems. Therefore, I analyzed the glutathione redox system and expression of
superoxide dismutase-1 (SOD-1) in WT and 123.7 cells to determine any
differences in their antioxidant response.
Specific Aim 2 was to determine whether PKA regulates hypoxia-induced
cell death via oxidative stress and/or energy depletion. In order to determine the
effect of PKA on hypoxia-induced energy failure, WT and 123.7 cells were
exposed to either room air or sustained hypoxia, and ATP levels were analyzed.
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Furthermore, cAMP levels were measured in the two cell lines at both room air
and hypoxic conditions to determine any differences. In the 123.7 cells, cAMP is
unable to bind to the regulatory subunits of PKA. This could potentially affect
cAMP synthesis or degradation and alter cAMP levels within the cells.
Oxidative stress may contribute to hypoxia-induced PC-12 cell death
through its effects on energy depletion, or directly through damage to intracellular
components. WT and 123.7 cells were pre-treated with the antioxidant N-acetyl
cysteine one hour prior to their hypoxic exposure. ROS levels were analyzed to
assess the effectiveness of the antioxidant in decreasing oxidative stress, and
cell survival was analyzed to determine the role of ROS in hypoxia-induced PC12 cell death. ATP and cAMP levels were examined following antioxidant
treatment to establish the role of ROS in hypoxia-induced energy failure.
PKA has been shown to regulate energy production through its control of
enzymes in the glycolytic pathway and the mitochondrial electron transport chain.
Thus for Specific Aim 3, I wanted to determine whether PKA affects cellular
energetic status through regulation of metabolic pathways. In particular, it was
important to determine (1) whether PKA plays a role in regulation of
mitochondrial function and (2) whether PKA activity has an effect on glycolytic
flux. An antioxidant was used to determine whether hypoxia-induced oxidative
stress directly regulates the metabolic pathways. Mitochondrial function of WT
and 123.7 cells was assessed through the expression of cytochrome oxidase,
and measurement of the mitochondrial membrane potential. Glycolytic flux was
analyzed by measuring the extracellular pH, glucose, lacate and pyruvate levels.
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In order to confirm the role of PKA in these processes, for Specific Aim 4, I
determined whether restoration of PKA activity in 123.7 cells abrogated
differences in hypoxic susceptibility and energy homeostasis between the two
cell lines. The PKA-activity deficient 123.7 cells were transfected with an active
catalytic a subunit of Protein Kinase A. Transfection efficiency was verified
through PKA activity assays and western blotting of the PKA cat a subunit.
Using the transfected cells, hypoxia-induced cell survival, oxidative stress,
energy status, glycolytic flux, and mitochondrial function were examined to
confirm the role of PKA in these processes.
Through these experiments, I hoped to determine the role of Protein
Kinase A in hypoxia-induced cell death. Clarification of the cellular response to
low oxygen conditions is essential to the treatment of pathologies characterized
by periods of hypoxia. Understanding the role of PKA in the regulation of cellular
metabolic responses, oxidative stress, and cell survival to hypoxia may provide
novel therapeutic opportunities to improve cellular adaptation and recovery.
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Specific Aim 1: To determine whether PKA activity affects cellular tolerance to
hypoxia and production of oxidant species
1 (A) To iderdify PKA-medlated changes In hypoxic vulnerability
WTcells
123.7 cells

RA, SH 0.1% 02

MlT I Trypan Blue

Cell survival

1 (8) To determine the role of PKA in hypoxl.induced oxidant stress
WTcells
123.7 cells

RA, SHO.1% 02
DCF
2',7'·dichloroftuorescein

ROS

1 (C) To determine whether PKA plays a role In the regulation of cellular antioxidant
mechanisms that will affect hypoxia-induced oxidative stress

WTcells
123.7 cells

RA, SH 0.1% 02

Cellular redox status
GSH/GSSG
Total Glutathione
SOO·1 Western Blotting
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Specific Aim 2: To determine whether PKA regulates hypoxia-induced cell
death via oxidative stress and/or energy depletion
2 (A) PKA effect on hypoxia-Induced energy failure
WTcells
123.7 cells

RA,SHO.1%02
I

Cellular energy status

ATP,cAMP

2 (8) To determine whether ROS contribute to hypoxia-induced energy failure

WTce11s
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RA, SH 0.1% 02
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Specific Aim 3: To determine whether PKA affects cellular energetic status
through regulation of metabolic pathways
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Glycolytic flux

Specific Aim 4: To determine whether restoration of PKA activity in 123 .7
cells will abrogate differences in hypoxic susceptibility and energy
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Mitochondrial Function

MATERIALS AND METHODS

Cell Culture and Hypoxic Exposures: WT and PKA-deficient (123.7) PC-12 cells

were kindly provided by Dr. JA Wagner from Cornell University and grown on
collagen coated plates in RPMI1640 medium (Gibco/lnvitrogen, Carlsbad, CA),
supplemented with 10% horse serum and 5% fetal bovine serum. Cells were
exposed to hypoxia (0.1 % or 5% O2, 5% CO2, balanced N2)' using a customdesigned, computer controlled incubator chamber attached to an external 02/C0 2
computer-driven controller (Biospherix, Redfield, NY) as previously described
(48,49).

Cell viability: Cell viability was measured as previously described (45,49,50) by

assessment of 3-(4,5-dimethyldiazol-2yl)-2,5,-diphenyltetrazolium bromide (MIT)
reduction (Sigma Chemical, St. Louis, MO). MIT was added to the cell cultures
one hour prior to the end of the hypoxic exposure and incubated at 37°C. Cells
were collected by centrifugation and resuspended in DMSO for 24h. Absorption
of reduced MIT was measured at 340 nm using a Multiskan EX plate reader
(Thermo electron corporation, Milford, MA) and values for DMSO blanks were
subtracted. Cell survival was also analyzed using Trypan Blue (J.T. Baker,
Philipsburg, NJ) exclusion as a marker of live cells with intact membranes. Cells
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were collected, resuspended in PBS/trypan, counted using a hematocytometer,
and total cell number was calculated and averaged.

cAMP determination: Intracellular cAMP levels were determined using a
chemiluminescent immunoassay kit according to the manufacturer's instructions
(Upstate, Temecula, CA). In this kit, a 96-well plate was precoated with a
capture antibody. Standards and samples were mixed with an anti-cAMP
antibody, as well as an alkaline phosphatase-labeled cAMP conjugate. The
conjugate competes with native cAMP in the standards and samples for binding
sites on the antibody. Thus, chemiluminescence levels are inversely related to
the amount of cAMP in the standards and samples. Luminescence was detected
using a SpectraFluor Plus (Tecan, San Jose, CA).

A TP determination: Intracellular ATP levels were determined using a
bioluminescence ATP determination kit according to the manufacturer's
instructions (Alexis Biochemicals, San Diego, CA). In this kit, the enzyme
luciferase uses endogenous cellular ATP to catalyze the formation of light from
luciferin. Luminescence was detected using a Spectra Fluor Plus (Tecan, San
Jose, CA).

Reactive oxygen species: Formation of intracellular oxidant speCies was detected
by fluorescence, using the cell permeable, non-fluorescent 2'-7'
dichlorodihydrofluorescin diacetate (DCFH 2-DA; Molecular Probes, Eugene, OR),
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which is de-esterified in cells by endogenous esterases and trapped. 2'-7'
dichlorofluorescin is oxidized by intracellular oxidant species to fluorescent 2'-7'
dichlorofluorescein. Cells were loaded for 1h with 5 ~M DCFH2-DA, washed, and
fluorescence was measured at 485 nm excitation and 535 nm emission using a
SpectraFluor Plus (Tecan, San Jose, CA) For antioxidant treatments, cells were
pretreated with 2.5 mM N-acetyl cysteine (Sigma, S1. Louis, MO) for 1 hour prior
to hypoxic exposure.

Extracellular Glucose determination: Growth media was analyzed for glucose
levels using the Amplex Red Glucose/Glucose Oxidase Assay Kit (Molecular
Probes, Eugene, OR). In this assay, D-glucose present in the growth media
reacts with glucose oxidase to from D-gluconolactone and hydrogen peroxide
(H202). The Amplex Red reagent (10-acetyl-3,7-<iihydroxyphenoxazine) reacts
with H202 in the presence of horseradish peroxidase to generate the fluorescent
product, resorufin. Fluorescence was measured in a 96-well plate at 550 nm
excitation and 595 nm emission using a SpectraFluor Plus (Tecan, San Jose,
CA)

Extracellular Lactate determination: Growth media samples without phenol red
were collected from cell cultures, deproteinized with perchloric acid, and
centrifuged at 8,000 rpm for 5 min at 4°C. Samples were neutralized using a
KOH/Na2HP04 solution and added in duplicate to a 96-well plate, with lactate
standards and controls. The assay reactant (O.2M Glycine-semicarbazide, 0.003
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M NAD, and 14 U/ml lDH) was added to the samples and incubated for 1h at
37°C. Optical density was read at 340 nm and subtracted from background
using a SpectraFluor Plus (Tecan, San Jose, CA). All chemicals were analytical
grade (Sigma Chemical, St. louis, MO).

Extracellular Pyruvate determination: Growth media samples without phenol red
were collected from cell cultures, deproteinized with perchloric acid, and
centrifuged at 8,000 rpm for 5 min at 4°C. Samples were neutralized using a
KOH/Na2HP04 solution and added in duplicate to a 96-well plate, with pyruvate
standards and controls. The assay reactant (0.083 M Tris-HCl, 0.0083 M EDTA,
0.75 mM NADH, 15 U/ml lDH) was added to the samples and incubated for 15
min at room temperature. Optical density was read at 340 nm and subtracted
from background using a SpectraFluor Plus (Tecan, San Jose, CAl. All
chemicals were analytical grade (Sigma Chemical, St. louis, MO).

Preparation of Cell Lysates and Western Blotting: Cells were collected by
centrifugation and pellets were resuspended in RIPA buffer (PBS, 1% NP-40,
0.5% Deoxycholate, 1% SDS, 1 mM Sodium orthovanadate, 0.5 mM PMSF, 10

mg/ml Aprotinin, 20 mg/ml leupeptin), incubated on ice for 30 min., briefly
sonicated, and centrifuged at 4°C at 15,000 rpm for 10 min. Total protein
concentration in the supernatant was determined using a DC-Bio-Rad protein
assay (Bio-Rad, Hercules, CAl. Immunoblotting was done as described
previously (5,47,49,51 ,52). Samples were diluted in buffer (125 mM Tris, 5%
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Glycerol, 4% Sodium dodecyl sulfate, 0.1 M Dithiothreitol, 0.0025% Pyronin Ypink, ddH 20) and loaded onto 4-12% Tris-Glycine gels (Invitrogen, Carlsbad, CA).
Gels were run in buffer (25 mM Tris, 193 mM Glycine, 0.1 % Sodium dodecyl
sulfate, ddH20) for 2h at 120 V, and transferred onto nitrocellulose filter
membranes for 1h at 30V in transfer buffer (12 mM Tris, 96 mM Glycine, 20%
Methanol). Membranes were stained with Ponceau-S to ensure proper transfer,
and blocked (5% non-fat dry milk in Tris buffered saline and 0.05% Tween-20) for
1 hour. Membranes were incubated with primary antibodies overnight at 4°C,
washed, and incubated with secondary antibodies for 1h at room temperature.
Membranes were then washed, and chemiluminescence was detected using an
ECl plus western blotting detection kit (GE Healthcare, Buckinghamshire, UK).
Membranes were immunoblotted for j3-actin to ensure loading efficiency.

Mitochondrial Membrane Potential Assay (MMP): MMP was determined with the
fluorescent probe 5,5' ,6,6' -tetrachloro-1 ,1' ,3,3' -tetraethylbenzimidazolyl
carbocyanine iodide (JC-1). JC-1 undergoes a reversible change in fluorescence
emission from green to red upon an increase in mitochondrial potential. Thus, in
live cells, JC-1 acccumulates as red aggregates in the mitochondria, while in
apoptotic or necrotic cells it remains in the green monomeric form. The
fluorescence ratio was detected in a 96-well plate according to the
manufacturer's instructions (Cell Technology, Mountain View, CA). Red
fluorescence was measured at 550 nm excitation and 595 nm emission, and
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green fluorescence was measured at 485 nm excitation and 535 nm emission
using a SpectraFluor Plus (Tecan, San Jose, CA).

Glutathione (GSHIGSSG) ratio and Total Glutathione: The glutathione ratio and
total glutathione levels were determined using a fluorescent kit according to the
manufacturer's instructions (Biovision, Mountain View, CA). In this kit 0phthalaldehyde reacts with the reduced form of glutathione (GSH), but not the
oxidized form (GSSG), to form a fluorescent product. GSH, GSSG, and total
glutathione levels were detected in separate wells in a 96-well plate. In order to
detect GSSG, a GSH quencher was added to rid the samples of endogenous
GSH. GSSG in the samples was then converted to GSH using a reducing agent,
and fluorescence was detected. To detect total glutathione, the reducing agent
was added to convert endogenous GSSG to GSH, and fluorescence was
measured using a SpectraFluor Plus (Tecan, San Jose, CA).

Cell Transfection: Tranfections were done using the FuGENE HD transfection
reagent (Roche Applied Science, Indianapolis, IN). Plasmids encoding active
PKA-cat a were kindly provided by Dr. G. Stanley McKnight, and used as
previously described (53). pcDNA 3.0 (Invitrogen, Carlsbad, CA) was used as a
vector control with FuGene reagent.

PKA Activity Assay: PKA activity was analyzed as previously described (54).
Cells were collected and lysed as described above, and total protein
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concentration in the supernatant was determined using a DC-Bio-Rad protein
assay (Bio-Rad, Hercules, CA). Duplicate samples (50 Ilg protein) were diluted
in Kinase Buffer (25 mM Hepes, pH 7.4; 20 mM MgCI2; 20 mM~
glycerophosphate; 0.1 mM Sodium orthovanadate; 2 mM DTT, 1 mL dd H2 0), in
the presence or absence of a PKA inhibitory peptide, PKI 6-22 amide (26.7 IlM,
Calbiochem, La Jolla, CA) to account for PKA-independent phosphorylation.
Reaction Buffer (200 IlM Kemptide; 55.6 nM 32P-ATP; Kinase Buffer) was added
and samples were incubated for 30 min at 30°C in a water bath. Aliquots of each
sample were removed from the tube and spotted on Whatman filter paper p81
(Whatman International Ltd, Maidstone, England). Filter papers were washed for
5 minutes with 1% phosphoric acid and the waste was drained. Washes were
repeated for 15 min with 1% phosphoric acid, and 15 minutes with ddH 2 0 to
remove non-specifically bound radioactivity. Radioactivity, representative of 32P
incorporation into the substrate, was counted using a Packard Tri-carb Liquid
Scintillation Analyzer 2100TR (Perkin Elmer Life & Analytical Sciences, Shelton,
CT).

Statistical Analyses: Statistical analyses were performed using SigmaStat
software version 3.5.1 (Systat Software, Inc., San Jose, CA). Data represented
as the means of individual experiments, with the error bars indicating standard
deviations. Statistical tests were performed as indicated in the results, with
significance defined as p<.05.
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RESULTS:

Specific Aim 1: To determine whether PKA activity affects cellular tolerance to
hypoxia and production of oxidant species

1 (A) Effect of PKA activity on cell survival to hypoxia: MTT assays indicated that
severe hypoxia induced cell death by 24h in WT cells, while a milder hypoxic
challenge did not significantly affect cell survival (Figure 10). In contrast, 123.7
cells did not exhibit cell death following 24h of severe hypoxic exposure (Figure
11). In addition, basal MTT values were also lower in 123.7 cells, compared to
WT cells at a similar confluence, as verified by Trypan Blue exclusion assays
(Figure 12). This indicates that PKA activity contributes to PC-12 hypoxic cell
death. The consistent difference in cellular reductive capacity, as indicated by
the MTT assays, implicates PKA signaling in the regulation of cellular metabolism
and suggests that the metabolic function of the two cell lines may differ.
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Figure 10. Cellular Tolerance of WT cells to Sustained Hypoxia: MTT Assay
WT cells were exposed to room air (RA), severe hypoxia (SH 0.1 % oxygen), or a
milder hypoxia (SH 5% oxygen). Cell viability was analyzed using the reduction
of MTT (3-(4,5-dimethyldiazol-2yl)-2,5,-diphenyltetrazolium bromide). WT cell
death occurred following 24h of severe (0.1 % 02) hypoxia, but was not seen at
any other time point of severe hypoxia, or with milder hypoxic exposure. Data
expressed as the means of 5 individual experiments (n=5), with error bars
indicating standard deviations. One-way ANOVA, Mann Whitney Rank Sum test.
* p<.01 SH vs. RA control at one time point, + p<.01 SH 0.1 % vs. SH 5% at one

time point.
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Figure 11. Cellular Tolerance of 123.7 cells to Sustained Hypoxia: MTT
Assay PKA-activity deficient 123.7 cells were exposed to room air (RA), severe
hypoxia (SH 0.1% oxygen), or a milder hypoxia (SH 5% oxygen). Cell viability
was analyzed using the reduction of MTT (3-(4,5-dimethyldiazol-2yl)-2,5,diphenyltetrazolium bromide). MTT reduction in 123.7 cells was significantly
increased from RA controls at later time pOints of hypoxic exposure, indicating
that 123.7 cells are not experiencing cell death over this time course. Data
expressed as the means of 5 individual experiments (n=5), with error bars
indicating standard deviations. One-way ANOVA, Tukey post-hoc test, * p<.01
RA control vs. SH at one time point.
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Figure 12. Trypan Blue Exclusion Assay WT and 123.7 cells were exposed
to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h. Cell
viability was assessed using the Trypan Blue exclusion assay. The number of
live cells per well was significantly decreased in WT cells following 24h of severe
hypoxia, while 123.7 cells had no change in the number of live cells. Data
expressed as means of 10 individual experiments (n=10), with error bars
indicating standard deviations. Two-way ANOVA, Tukey post-hOC test, *p<.001
RA vs. SH 0.1 % 02 for one cell line.
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1 (8) Effect of PKA activity on Oxidative Stress: DCF fluorescence, indicating
reactive oxygen species production, significantly increased in WT cells exposed
to 24h severe hypoxia (0.1% 02) (Figure 13). In contrast to WT cells, the PKAactivity deficient 123.7 cells had no significant alterations in DCF fluorescence
following exposure to 0.1 % O2 for 24h, (Figure 13), suggesting that PKA activity
contributes to ROS formation.
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Figure 13. Reactive Oxygen Species Production: DCF Fluorescence WT and
123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia
(SH 0.1 %) for 24h. ROS levels, as detected by dichlorofluorescein (DCF)
fluorescence, were significantly increased in WT cells following 24h of severe
hypoxia, while 123.7 cells experienced no significant alterations in DCF
fluorescence. Data expressed as the means of the relative fluorescence units
(RFU) from 14-16 individual experiments (n=14-16), with error bars indicating
standard deviations. Two-way ANOVA, Tukey Post-hoc test, *p<.001 RA vs. SH
0.1 % 02 for one cell line.
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1 (C) Effect of PKA on cellular antioxidant response: Following 24h of severe
hypoxia, there was surprisingly no detectable difference in the GSH/GSSG ratio
(Figure 14) or total glutathione levels in either WT or 123.7 cells (Figure 15).
However, it is important to note that most of the detected glutathione was in the
oxidized (GGSG) state during both normoxic and hypoxic states. This indicates
that, in our PC-12 cell lines, the reductive capacity of the glutathione system may
already be compromised, even during normoxic conditions. Furthermore,
superoxide dismutase 1 (SOD-1) expression was not altered in either cell line
with 24h of sustained hypoxia or with antioxidant treatment (Figure 16), indicating
that the antioxidant response of PC-12 cells may be compromised by this time.
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Figure 14. Cellular Redox Status: GSH/GSSG ratio WT and 123.7 cells were
exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h.
The ratios of reduced to oxidized forms of glutathione were analyzed as an
indicator of cellular antioxidant response. Data expressed as the means of the
relative fluorescence units (RFU) from 5 individual experiments (n=5), with error
bars indicating standard deviations. Two-way ANOVA statistics did not detect a
significant difference between the GSH/GSSG ratios of the two cell types, or
between room air and hypoxia treated groups in each cell line.
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Figure 15. Cellular Redox Status: Total Glutathione The total levels of
glutathione were assessed in WT and 123.7 cells exposed to either room air (RA)
of sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h. Data expressed as means of
the relative fluorescence units (RFU) of 5 individual experiments (n=5), with error
bars indicating standard deviations.

Two~way

ANOVA statistics did not detect a

significant difference between the total glutathione levels of the two cell types, or
between room air and hypoxia treated groups in each cell line.
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Figure 16. Cellular Antioxidant Capacity: 500-1 Expression WT and 123.7
cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (8H
0.1 %) for 24h. Groups were also pre-treated for 1h with the antioxidant
precursor N-acetyl cysteine (NAC). Western blotting of superoxide dismutase-1
(800-1 ) was performed to analyze the cellular antioxidant responses, and
loading efficiency was confirmed through immunoblotting of f3-actin. No
alterations in 800-1 or f3-actin expression were seen between the WT and 123.7
cells, or in either cell line upon hypoxic exposure or with antioxidant pretreatment. Data representative of 3 individual experiments.
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Specific Aim 2: To determine whether PKA regulates hypoxia-induced cell death
via oxidative stress and/or energy depletion

2 (A) Effect of PKA Activity on Cellular Energetic Status: Severe hypoxia
decreased ATP levels in WT cells by 24h, while 123.7 cells displayed no change
in ATP levels (Figure 17). Furthermore, 123.7 cells had a lower basal level of
ATP, indicating that PKA activity may playa role in determining cellular energy
requirements. The hypoxia-induced decrease in ATP coincided with the onset of
cell death in WT cells, however lower baseline ATP levels did not appear to be
detrimental to 123.7 cell survival.
In 123.7 cells, the mutated PKA regulatory subunit prevented the binding
of cAMP, and thus, could potentially affect cAMP synthesis or degradation and
alter cAMP levels within the cells. However, there was no alteration of cAMP
levels between the WT and 123.7 cells, or upon exposure to 24h of severe
hypoxia (Figure 18), suggesting that cAMP levels are not altered by hypoxia or
PKA activity.
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Figure 17. Cellular Energetic Status: AlP levels WT and PKA activitydeficient 123.7 cells were exposed to either room air (RA) or sustained 0.1% O2
hypoxia (SH 0.1%) for 24h. ATP levels were significantly decreased in WT cells
following 24h of hypoxic exposure, while 123.7 cells displayed no change in ATP
levels. The 123.7 cells also had a lower basal level of ATP than WT cells. Data
expressed as the means of relative luminescence units (RLU) from 7 individual
experiments (n=7), with error bars indicating standard deviations. Two-way
AN OVA, Tukey Post-hoc test, ** p<.005 as indicated, * p<.01 RA vs. SH 0.1%
24h in each cell line.
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Figure 18. Cellular Energetic Status: cAMP levels WT and 123.7 cells were
exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h,
and their cAMP levels were analyzed. Two-way ANOVA statistics did not detect
a significant difference between the cAMP levels of the two cell types, or
between room air and hypoxia treated groups in each cell type. Data expressed
as the means of 5-6 individual experiments (n=5-6), with error bars indicating
standard deviations.
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2 (8) Effect of ROS on Hypoxia-induced Energy Failure Pre-treatment of WT
cells with the antioxidant N-acetyl cysteine, 1h prior to 24h SH 0.1 % 02, reduced
ROS levels as detected by DCF fluorescence (Figure 19). Antioxidant treatment
also improved cell survival assessed by Trypan blue exclusion (Figure 20),
indicating that oxidative stress contributes to hypoxia-induced PC-12 cell death.
N-acetyl cysteine treatment led to a drastic shift in the reduction state of
the cell, as shown by the large increase in the GSH/GSSG ratio in both normoxic
and hypoxic conditions (Figure 21). However, N-acetyl cysteine treatment did
not affect the total glutathione levels in the cell (Figure 22), indicating that the
antioxidant may be directly acting as a reducing agent for the existing pool of
oxidized GSSG rather than increasing generation of new glutathione.
Furthermore, pretreatment with the antioxidant N-acetyl cysteine, while
rescuing WT cells from cell death, had no effect on ATP levels (Figure 23),
suggesting that oxidative stress may not be sufficient to induce cellular energy
depletion during hypoxia. This data suggests that while hypoxic stress depletes
ATP levels, energy depletion does not appear to be directly causing death.
cAMP levels were not Significantly affected by treatment with the antioxidant Nacetyl cysteine in either of the cell types (Figure 24), suggesting that cAMP levels
are not altered by oxidative stress.
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Figure 19. Effect of Antioxidant treatment on DCF Fluorescence WT and
123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia
(SH 0.1 %) for 24h. Dichlorofluorescein (DCF) fluorescence, indicative of ROS
levels, was analyzed in cells pre-treated with the antioxidant N-acetyl cysteine
relative to untreated controls. N-acetyl cysteine treated groups had lower values
of DCF fluorescence than the untreated controls. Data expressed as the means
of relative fluorescence units (RFU) from 5-6 individual experiments (n=5-6), with
error bars indicating standard deviations. Two-way ANOVA, Tukey Post-hoc test,
** p<.001, * p<.05 N-acetyl cysteine treated cells vs. non-treated cells of the

same condition.
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Figure 20. Effect of Antioxidant treatment on Trypan Blue Exclusion Assay

WT and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02
hypoxia (SH 0.1 %) for 24h. Trypan Blue exclusion assays were analyzed in cells
pre-treated with the antioxidant N-acetyl cysteine relative to untreated controls to
analyze cell viability. WT cells exposed to hypoxia had a significant increase in
the number of live cells when pre-treated with N-acetyl cysteine, while the
antioxidant treatment did not have a significant effect on the other groups tested.
Data expressed as the means of 5 individual experiments (n=5), with error bars
indicating standard deviations. Two-way ANOVA, Tukey Post-hoc test, * p=.01
N-acetyl cysteine pre-treated cells vs. non-treated cells of the same oxygen
condition and cell line.
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Figure 21. Effect of Antioxidant treatment on GSH/GSSG ratio WT and
123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia
(SH 0.1%) for 24h. The ratio of reduced to oxidized glutathione (GSH/GSSG),
indicative of cellular antioxidant status, was analyzed in cells pre-treated with the
antioxidant N-acetyl cysteine relative to untreated controls. Pre-treatment with
the antioxidant significantly increased the ratio of reduced to oxidized glutathione
in all of the groups tested. Data expressed as the means of relative fluorescence
units (RFU) from 5 individual experiments (n=5), with error bars indicating
standard deviations. Two-way ANOVA, Tukey post hoc t-test, p<.001 N-acetyl
cysteine pre-treated cells vs. non-treated cells of the same oxygen condition and
cell line.
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Figure 22. Effect of Antioxidant Treatment on Total Glutathione Levels WT
and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02
hypoxia (SH 0.1 %) for 24h. Total glutathione levels were analyzed in cells pretreated with the antioxidant N-acetyl cysteine relative to untreated controls.
Antioxidant treatment did not have an effect on any of the tested groups. Data
expressed as the means of relative fluorescence units (RFU) from 5 individual
experiments (n=5), with error bars indicating standard deviations. One-way
ANOVA statistics did not detect a significant difference between the total
glutathione levels of N-acetyl cysteine pre-treated cells vs. non-treated cells in
WT or 123.7 cells.
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Figure 23. Effect of Antioxidant treatment on ATP levels WT and 123.7 cells

were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 0.1%)
for 24h. ATP levels were analyzed in cells pre-treated with the antioxidant Nacetyl cysteine relative to untreated controls. Antioxidant treatment had no effect
on ATP levels in any of the tested groups. Data expressed as the means of
relative luminescence units (RLU) from 4 individual experiments (n=4), with error
bars indicating standard deviations. One-way ANOVA statistics did not detect a
significant difference between the ATP levels of N-acetyl cysteine pre-treated
cells vs. non-treated cells in WT or 123.7 cells.
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Figure 24. Effect of Antioxidant treatment on cAMP levels WT and 123.7

cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH
0.1%) for 24h. cAMP levels were analyzed in cells pre-treated with the
antioxidant N-acetyl cysteine relative to untreated controls. Antioxidant treatment
had no effect on the levels of cAMP in any of the tested groups. Data expressed
as the means of 5-6 individual experiments (n=5-6), with error bars indicating
standard deviations. One-way ANOVA statistics did not detect a significant
difference between the cAMP levels of N-acetyl cysteine pre-treated cells vs.
non-treated cells in WT or 123.7 cells
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Specific Aim 3: To determine whether PKA affects cellular energetic status
through regulation of metabolic pathways

3 (A) Effect of PKA on mitochondrial potential and abundance: WT and PKA
activity-deficient 123.7 cells had a small, insignificant decrease in JC-1 ratio upon
hypoxic exposure (Figure 25). However, 123.7 cells exhibited higher JC-1
red/green ratios than WT cells overall (Figure 25). While treatment with the
antioxidant N-acetyl cysteine rescued WT cells from hypoxic cell death, it did not
restore RA JC-1 ratios (Figure 25), suggesting that mitochondrial potential is not
the primary cause of cell death at 24h hypoxia. These data suggests that
mitochondrial potential may be compromised at the onset of cellular death, and
that PKA may have an inhibitory effect on mitochondrial metabolism.
COX IV expression decreased after 24h SH in both cell lines (Figure 26).
However, 123.7 cells displayed significantly higher expression of COX IV than
WT cells during RA and SH 0.1 % 24h (Figure 26), suggesting an increase in
mitochondrial enzyme or a mitochondrial enrichment when PKA was inactivated.
Pretreatment with NAC did not prevent the SH-induced decrease in COX IV
expression (Figure 26), suggesting again that increases in ROS may occur
independently, or downstream of the hypoxia-induced metabolic changes.

48

12

5' 10
u..
~
Q)

U
C

Q)

8

U

en

e
o
u:
~

6

C

CD

e

~

'C

4

....~
I

o

~

2

o
WT RA 24h

WT RA +
NAC

WT SH 0.1%
24h

WT SH +
NAC

123.7 RA
24h

123.7 RA +
NAC

123.7 SH
0.1% 24h

123.7 SH +
NAC

Figure 25. Mitochondrial Potential: JC-1 Assay WT and 123.7 cells were
exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h.
Fluorescence of 5,5' ,6,6' -tetrachloro-1 ,l' ,3,3' -tetraethylbenzimidazolyl
carbocyanine iodide (JC-1) was analyzed as an indicator of mitochondrial
potential. Cells were pre-treated with the antioxidant N-acetyl cysteine and
compared to untreated controls. Exposure to hypoxia resulted in a small,
insignificant decrease in JC-1 fluorescence, but antioxidant treatment had no
effect on JC-1 fluorescence ratios. The 123.7 cells, however, had higher overall
JC-1 levels than WT cells. Data expressed as the means of relative fluorescence
units (RFU) from 5 individual experiments (n=S), with error bars indicating
standard deviations. Two-way ANOVA, Tukey post hoc t-test, p<.OS WT vs.
123.7 cells.
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Figure 26. Effect of Antioxidant Treatment on COX IV Expression WT and
123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia
(SH 0.1 %) for 24h. Cells were pre-treated with the antioxidant N-acetyl cysteine
(NAC) and compared to untreated controls. The expression of cytochrome
oxidase IV (COX IV) was analyzed and loading efficiency was confirmed through
immunoblotting of p-actin. Both WT and 123.7 cells had a decrease in COX IV
expression after 24h of hypoxic exposure. However, 123.7 cells displayed higher
COX IV expression than WT cells at both room air and sustained hypoxia. Nacetyl cysteine treatment had no effect on COX IV protein levels. Results
representative of 3 individual experiments (n=3).
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3 (8) Effect of PKA activity on glycolytic flux: Media glucose levels were lower in
normoxic WT cells 24h after plating the cells, compared to 123.7 cells (Figure
27), indicating that WT cells have higher rate of glucose consumption and may
have higher metabolic requirements for their basal metabolism. Hypoxia
enhanced these differences between the cell types, with an increased uptake of
glucose in 123.7 cells, but complete depletion of extracellular glucose in WT
cells.
Extracellular pH decreased in both cell types upon hypoxic exposure
(Figure 28), but WT cells displayed lower pH values under normoxic and hypoxic
conditions. Hypoxia increased lactate production in both cell types (Figure 29), as
expected from their increased glucose utilization, suggesting upregulation of
anaerobic metabolism. However, WT cells displayed higher lactate values at
normoxic and hypoxic states, indicating that PKA signaling may enhance
glycolytic flux.
In addition, WT cells exhibited higher extracellular pyruvate levels under
normoxic conditions (Figure 30), but were unaffected by hypoxic exposure. The
PKA activity-deficient 123.7 cells displayed an increase in extracellular pyruvate
upon hypoxic challenge (Figure 30).
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Figure 27. Glyolytic Flux: Extracellular Glucose WT and 123.7 cells were
exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h.
Extracellular glucose levels were significantly lower in WT cells than in 123.7
cells following 24h of RA exposure. Hypoxic exposure enhanced these
differences, with depletion of extracellular glucose stores in the WT cell line.
Data expressed as the means of 8-10 individual experiments (n=8-10), with error
bars indicating standard deviations. Two-way ANOVA, Tukey Post-hoc test, *
p<.001 as indicated.
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Figure 28: Glycolytic Flux: Extracellular pH WT and 123.7 cells were
exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 0.1 %) for 24h.
Both WT and 123.7 cells had a drop in extracellular pH following 24h of hypoxic
exposure. However, extracellular pH was higher in 123.7 cells than in WT cells
in both normoxic and hypoxic conditions. Data expressed as the means of 10
individual experiments (n=10), with error bars indicating standard deviations.
Tukey Post-hoc test, * p<.05 as indicated or RA 24h vs. SH 0.1 % 24h in each cell
line.
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Figure 29. Glycolytic Flux: Extracellular Lactate WT and 123.7 cells were
exposed to either room air (RA) or sustained 0.1% O2 hypoxia (SH 0.1%) for 24h.
Extracellular lactate was increased in both WT and 123.7 cells following hypoxic
exposure. However, WT cells had higher extracellular lactate levels than 123.7
cells in both normoxic and hypoxic conditions. Data expressed as the means of
10 individual experiments (n=10), with error bars indicating standard deviations.
Two-way ANOVA, Tukey Post-hoc test, * p s .001 as indicated or RA 24h vs. SH
0.1 % 24h in each cell type.
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Figure 30. Glycolytic Flux: Extracellular Pyruvate WT and 123.7 cells were
exposed to either room air (RA) or sustained 0.1% O2 hypoxia (SH 0.1%) for 24h.
WT cells had a higher level of extracellular pyruvate than 123.7 cells under
normoxic conditions, but experienced no change in extracellular pyruvate after
24h of sustained hypoxia. The 123.7 cells, however, had significantly higher
levels of extracellular pyruvate following hypoxic exposure. Data expressed as
the means of 10 individual experiments (n=10), with error bars indicating
standard deviations. Two-way ANOVA, Tukey Post-hoc text, ** p<.001 as
indicated, * p<.01 RA 24h vs. SH 0.1 % 24h in each cell type.
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3 (C) Effect of Hypoxia-Induced Oxidant Stress on Glycolytic Flux: Extracellular
glucose levels were unaffected by antioxidant treatment with N-acetyl cysteine
(Figure 31). suggesting that PKA activity may contribute to the upregulation of
glucose use under hypoxic states independently from oxidative stress. Hypoxiainduced decreases in pH were also unaffected by NAC treatment (Figure 32).
Furthermore, treatment with N-acetyl cysteine did not affect lactate or pyruvate
values (Figures 33 and 34), indicating that oxidative stress does not alter
glycolytic rate.
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Figure 31. Effect of Antioxidant treatment on Extracellular Glucose WT and
123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia
(SH 0.1 %) for 24h. Cells were pre-treated with the antioxidant N-acetyl cysteine
and compared to untreated controls. One-way ANOVA statistics did not detect a
significant difference between the extracellular glucose levels of N-acetyl
cysteine pre-treated cells vs. non-treated cells in WT or 123.7 cells. Data
expressed as the means of 6-9 individual experiments (n=6-9), with error bars
indicating standard deviations.
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Figure 32. Effect of Antioxidant treatment on Extracellular pH WT and 123.7
cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH
0.1 %) for 24h. Cells were pre-treated with the antioxidant N-acetyl cysteine and
compared to untreated controls. One-way ANOVA statistics did not detect a
significant difference between the extracellular pH levels of N-acetyl cysteine pretreated cells vs. non-treated cells in WT or 123.7 cells. Data expressed as the
means of 7 individual experiments (n=7), with error bars indicating standard
deviations.
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Figure 33. Effect of Antioxidant Treatment on Extracellular Lactate WT and
123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia
(SH 0.1%) for 24h. Cells were pre-treated with the antioxidant N-acetyl cysteine
and compared to untreated controls. One-way ANOVA statistics did not detect a
significant difference between the extracellular lactate levels of N-acetyl cysteine
pre-treated cells vs. non-treated cells in WT or 123.7 cells. Data expressed as
the means of 7 individual experiments (n=7), with error bars indicating standard
deviations.
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Figure 34. Effect of Antioxidant Treatment on Extracellular Pyruvate WT
and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02
hypoxia (SH 0.1 %) for 24h. Cells were pre-treated with the antioxidant N-acetyl
cysteine and compared to untreated controls. One-way ANOVA statistics did not
detect a significant difference between the extracellular pyruvate levels of Nacetyl cysteine pre-treated cells vs. non-treated cells in WT or 123.7 cells. Data
expressed as the means of 10 individual experiments (n=10), with error bars
indicating standard deviations.
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Specific Aim 4: To determine whether restoration of PKA activity in 123.7 cells
will abrogate differences in hypoxic susceptibility and energy homeostasis
between the two cell types.

Transfection of 123.7 cells with active PKA catalytic a subunit: 123.7 cells were
transfected with plasm ids encoding active PKA catalytic ex subunit to restore PKA
activity in these cells. Over-expression of PKA cat ex was verified by Western
blotting and PKA activity assays. Western blotting displayed an increase in PKA
cat ex expression in transfected cells at both RA and SH (Figure 35). Increased
PKA enzymatic activity in transfected 123.7 cells after 24h SH was detected by
PKA activity assays, which also verified transfection efficiency (Figure 36).
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Figure 35. Effect of PKA cat a Transfection on PKA cat a expression PKA
activity-deficient 123.7 cells were transfected with empty vectors or plasmids
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a.). Following
transfection, cells were exposed to either room air (RA) or sustained 0.1 % O2
hypoxia (SH 0.1%) for 24h. The expression of PKA cat-a. was analyzed and
loading efficiency was verified through immunoblotting of l3-actin. The mutant
123.7 cells transfected with the active catalytic subunit of PKA had increased
expression of PKA cat-a. under room air and sustained hypoxia conditions.
Results representative of 7 individual experiments (n=7).
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Figure 36. Effect of PKA cat a Transfection on PKA Activity levels PKA
activity-deficient 123.7 cells were transfected with empty vectors or plasm ids
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). Following
transfection, cells were exposed to ejther room air (RA) or sustained 0.1 % O2
hypoxia (SH 0.1 %) for 24h. The mutant 123.7 cells transfected with PKA cat-a
plasmids had higher levels of PKA activity than the vector controls under hypoxic
conditions. Data expressed as the means of the counts per minute (CPM) of 5
individual experiments (n=5), with error bars indicating standard deviations. Twoway ANOVA, Tukey post hoc t-test, * p<.OO5 PKA cat a transfected cells vs.
vector controls of the same oxygen condition.
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Effect of PKA cat a transfection on hypoxia-induced ROS production and cell
death: Transfection of 123.7 cells with an active catalytic subunit of PKA led to a
significant increase in hypoxia induced ROS production at 24h relative to RA
controls (Figure 37). However, WT cells still exhibited a larger increase in DCF
fluorescence upon hypoxic challenge. Furthermore, the increase in ROS
formation upon transfection in 123.7 cells did not result in a concomitant increase
in cellular death, even after hypoxic challenge, as shown by Trypan Blue
exclusion assays (Figure 38). Thus, although partially restoring PKA cat a in the
123.7 cells increased ROS response to hypoxic challenge, the response was
significantly below WT cell levels (Figure 37) and the resulting oxidative stress
did not induce cell death. These data suggests that additional signaling events
may contribute to ROS formation and cell death in WT cells.
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Figure 37. Effect of PKA cat a Transfection on Hypoxia-induced ROS Levels
PKA activity..cfeficient 123.7 cells were transfected with empty vectors or
plasm ids encoding the active catalytic subunit of Protein Kinase A (PKA cat-a).
WT and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02
hypoxia (SH 0.1%) for 24h. ROS levels, as detected by dichlorofluorescein
(DCF) fluorescence, were significantly increased in WT cells following 24h of
severe hypoxia, while 123.7 cells transfected with empty vectors experienced no
significant alterations in DCF fluorescence. The mutant 123.7 cells transfected
with PKA cat-a had a Significant increase in DCF fluorescence following hypoxic
exposure, but these values were lower than WT cells. Data expressed as the
means of relative fluorescence units (RFU) from 5 individual experiments (n=5),
with error bars indicating standard deviations. Two-way ANOVA, Tukey post hoc
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t-test, * p<.005 as indicated or PKA cat a transfected cells vs. vector controls of
the same oxygen condition, **p<.001 RA 24h vs. SH 0.1 % 24h.
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Figure 38. Effect of PKA cat a Transfection on Hypoxia-induced Cell Death
PKA activity-deficient 123.7 cells were transfected with empty vectors or
plasmids encoding the active catalytic subunit of Protein Kinase A (PKA cat-a).
WT and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2
hypoxia (SH 0.1 %) for 24h. Cell viability was assessed using the Trypan Blue
exclusion assay. The number of live cells per well was Significantly decreased in
WT cells following 24h of severe hypoxia, while transfected 123.7 cells had no
change in the number of live cells. Data expressed as the means of 10 individual
experiments (n=10), with error bars indicating standard deviations. Two-way
ANOVA, Tukey post hoc t-test, * p<.05 RA 24h vs. SH 0.1 % 24h for one cell line.
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Effect of PKA cat a transfection on hypoxia-induced metabolic response:
Transfection of 123.7 cells with PKA cat a. did not significantly change
extracellular pH (Figure 39), glucose consumption (Figure 40), lactate release
(Figure 41), pyruvate release (Figure 42), or COX IV expression (Figure 43)
relative to empty vector controls or untransfected cells. These findings suggest
that increased PKA activity affects ROS levels, without altering cell metabolism.
However, it can not be ruled out that prolonged PKA activation may be necessary
for upregulation of metabolism to the levels seen in WT cells. Alternatively, a
more sustained increase in ROS levels triggers metabolic responses which may
be induced by HIF-1 a. or NF-KB transcriptional activation.
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Figure 39. Effect of PKA cat a Transfection on Extracellular pH PKA
activity-deficient 123.7 cells were transfected with empty vectors or plasm ids
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a.). WT and
123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia
(SH 0.1%) for 24h. Both WT and transfected 123.7 cells had a drop in
extracellular pH following 24h of hypoxic exposure. However, extracellular pH
levels were higher in transfected 123.7 cells than in WT cells in both normoxic
and hypoxic conditions. Transfection of the 123.7 cells with PKA

cat-a had no

effect on the extracellular pH levels relative to the vector-transfected 123.7 cells.
Data expressed as the means of 10 individual experiments (n=10), with error
bars indicating standard deviations. Two-way ANOVA, Tukey post hoc t-test, *
p<.01 as indicated, ** p<.001 RA 24h vs. SH 0.1 % 24h for each condition.
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Figure 40. Effect of PKA cat a Transfection on Extracellular Glucose PKA
activity-deficient 123.7 cells were transfected with empty vectors or plasm ids
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). WT and
123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia
(SH 0.1 %) for 24h. Extracellular glucose levels were significantly lower in WT
cells than in transfected 123.7 cells following 24h of RA exposure. Hypoxic
exposure enhanced these differences, with depletion of extracellular glucose
stores in the WT cell line. Transfection of the 123.7 cells with PKA cat-a had no
effect on the extracellular glucose levels relative to the vector-transfected 123.7
cells. Data expressed as the means of 4-10 individual experiments (n=4-10),
with error bars indicating standard deviations. Two-way AN OVA, Tukey post hoc
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t-test, * p<.05 RA 24h vs. SH 0.1 % 24h for each condition, ** p<.001 as
indicated, or RA 24h vs. SH 0.1 % 24h for each condition.
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Figure 41. Effect of PKA cat a Transfection on Extracellular Lactate PKAactivity-deficient 123.7 cells were transfected with empty vectors or plasm ids
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). 123.7 cells
were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 0.1%)
for 24h. Extracellular lactate was increased in the 123.7 cells following hypoxic
exposure, but transfection of the 123.7 cells with PKA cat-a had no effect on the
extracellular lactate levels relative to the vector-transfected 123.7 cells. Data
expressed as the means of 5 individual experiments (n=5), with error bars
indicating standard deviations. Two-way ANOVA, Tukey post hoc t-test, p s .001
RA 24h vs. SH 0.1% 24h for each condition.
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Figure 42. Effect of PKA cat a Transfection on Extracellular Pyruvate PKAactivity-deficient 123.7 cells were transfected with empty vectors or plasmids
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). 123.7 cells
were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %)
for 24h. The 123.7 cells had significantly higher levels of extracellular pyruvate
following hypoxic exposure, but transfection of the 123.7 cells with PKA cat-a.
had no effect on the extracellular pyruvate levels relative to the vector transfected
123.7 cells. Data expressed as the means of 5 individual experiments (n=5), with
error bars indicating standard deviations. Two-way ANOVA, Tukey post hoc ttest, * p<.05 RA 24h vs. SH 0.1 % 24h for each condition.
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Figure 43. Effect of PKA cat a transfection on COX IV expression PKAactivity-deficient 123.7 cells were transfected with empty vectors or plasm ids
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). Cells were
exposed to either room air (RA) or sustained 0.1% 02 hypoxia (SH 0.1%) for 24h.
The expression of cytochrome oxidase IV (COX IV) was analyzed and loading
efficiency was confirmed through immunoblotting of f3-actin . The 123.7 cells had
a decrease in COX IV expression after 24h of hypoxic exposure. Transfection of
the 123.7 cells with PKA cat-a had no effect on the COX IV expression levels
relative to the vector transfected 123.7 cells. Results representative of 5
individual experiments (n=5).
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Effect of PKA cat a transfection on energetic status: Transfection of 123.7 cells
resulted in a small, but not statistically significant decrease in ATP levels (Figure
44), likely due to the short serum deprivation called for by the transfection
protocol. However, there was no significant difference in ATP levels between
123.7 cells transfected with PKA cat a relative to empty vector controls (Figure
44). Again, it can not be excluded that a longer PKA activation could trigger the
upregulation and maintenance of a higher metabolic rate similar to that seen in
WT cells.
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Figure 44. Effect of PKA cat a Transfection on ATP Levels PKA-activitydeficient 123.7 cells were transfected with empty vectors or plasmids encoding
the active catalytic subunit of Protein Kinase A (PKA cat-a). WT and 123.7 cells
were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 0.1 %)
for 24h. ATP levels were significantly decreased in WT cells following 24h of
hypoxic exposure, while 123.7 cells had no change in ATP levels. The 123.7
cells also had a lower basal level of ATP than WT cells. Transfection of 123.7
cells with PKA

cat-a had no effect on the ATP levels relative to the vector-

transfected 123.7 cells or non-transfected 123.7 cells. Data expressed as the
means of relative luminescence units (RLU) from 5-7 individual experiments
(n=5-7), with error bars indicating standard deviations. Two-way ANOVA, Tukey
post hoc !-test, * p<.005 RA 24h vs. SH 0.1% 24h for each condition.
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DISCUSSION

Hypoxia is characterized by an inadequate oxygen supply to the tissues in
proportion to their metabolic needs, and leads to an imbalance in energy
production and cell death.

While many hypoxic Signaling events have been

elucidated, the role of the Protein Kinase A (PKA) has yet to be clarified. PKA
has been attributed a function as both an anti-apoptotic kinase as well as a proapoptotic signal. Thus the contribution of PKA to hypoxia-induced cell survival is
currently unclear.
In order to examine the role of the PKA pathway in hypoxia-induced
signaling, I used a genetically altered line of PC-12 cells, 123.7 cells, which have
a mutated PKA I regulatory subunit. I hypothesized, based on the current
literature, that PKA activity regulates PC-12 hypoxic cell death via oxidative
stress and cellular energy depletion. Specific Aim 1 was to determine whether
PKA activity affects cellular tolerance to hypoxia and production of oxidant
species. WT and 123.7 cells were exposed to either room air or sustained 0.1 %
oxygen hypoxia for up to 24h. WT cells had significant cell death at 24h of
sustained hypoxia, while the PKA-activity deficient 123.7 cells had no cell death
at this time. This indicates that PKA activity contributes to hypoxia-induced cell
death, supporting our hypothesis that PKA regulates PC-12 hypoxic cell death.
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This supports earlier work, in which inhibitors of PKA were shown to have
protective effects against ischemia-reperfusion injury in the rabbit heart (17).
Activation of PKA has also been shown to be neuroprotective in a variety of
neuronal models (31).
A potential mechanism for PKA's deleterious effect in WT cells may
involve PKA regulation of the mitochondrial chain enzymes. PKA has been
shown to directly phosphorylate complexes I and IV of the mitochondrial electron
transport chain (16,17). The phosphorylation of Complex I results in increased
activity, while phosphorylation of Complex IV decreases its activity (16,17).
Complexes I and III have been identified as potential ROS leakage sites in the
mitochondrial electron transport chain (10). Therefore, the PKA-dependent
increase in activity of Complex I and decreased activity of Complex IV may result
in disruption of the electron flow and increased ROS leakage (16, 17). This may
shift the redox balance of the cell towards a state of oxidative stress.
Consequently, PKA activity may playa role in the modulation of hypoxia-induced
oxidative stress and cellular death.
Indeed, the onset of cell death in WT cells following 24 hours of severe,
sustained hypoxia correlates with an increase in oxidative stress as shown by
dichlorofluorescein (DCF) assays. In contrast, no such increase was detected in
123.7 cells. These data support our hypothesis that PKA activity contributes to
hypoxia-induced oxidative stress. Similar results have been found in rat
macrophages and cardiomyocytes, in which PKA activity contributes to the
formation of reactive oxygen species in the mitochondrial electron transport chain
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(17,59). Interestingly, neither the GSH/GSSG ratio nor SOD-1 expression were
altered in WT cells following hypoxia-induced oxidative stress. The absence of
antioxidant response in these cells may indicate that the antioxidant systems in
the PC-12 cell line are compromised at 24h.
The effects of PKA on the function of antioxidant systems have not been
well-characterized in the literature. The low levels of detected oxidative stress in
123.7 cells could be due to upregulation of antioxidant systems, and thus
enhanced detoxification of ROS. In the WT and 123.7 cells, there were no
significant differences in the GSH/GSSG ratio, total glutathione levels, or SOO-1
expression. Consequently, PKA activity does not appear to playa role in the
regulation of ce"ular antioxidant mechanisms in our experimental model. This
suggests that 123.7 cells have lower levels of hypoxia-induced ROS production,
rather than increased detoxification abilities.
Oxidative stress during hypoxia can directly lead to mitochondrial damage
and interruption of energy production by the mitochondrial electron transport
chain. Furthermore, during hypoxia, oxidative phosphorylation processes decline
and cells must progressively rely on anaerobic metabolism. This can present an
energy challenge for the cells, as glycolysis produces a net gain of only 2 ATP
relative to the approximately 36-38 ATP that can be produced by oxidative
phosphorylation and glycolytic processes combined.
Specific Aim 2 was to determine whether PKA regulates hypoxia-induced
cell death via oxidative stress and/or energy depletion. As expected, severe
hypoxia decreased ATP levels by 24 hours in WT cells, indicating that hypoxic
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exposure disrupts energy production. In contrast, 123.7 cells had a lower basal
level of ATP that did not further decrease following 24 hours of hypoxic exposure.
These data support our hypothesis that PKA activity regulates PC-12 cell death
via cellular energy depletion.
cAMP levels were also examined in these cells, as their mutated PKA
regulatory subunit prevents binding of cAMP and could thus potentially alter
cAMP levels within the cells and lead to changes in the energy pool. However,
there was no alteration in cAMP levels between WT and 123.7 cells during
normoxic or hypoxic incubation. This corroborates with earlier research showing
that the mutation of PKA in 123.7 cells had no effect on cAMP levels (47).
PKA inactivation may allow 123.7 cells to operate at a lower energy cost
under both normoxic and hypoxic states. This, in addition to their low ROS
levels, could provide a potential mechanism for their higher tolerance to hypoxic
injury. It has been well characterized that hypoxia-tolerant reptiles are able to
enter into a hypometabolic state and conserve energy (60, 61). Although it has
been speculated that protein kinases are responsible for the adaptive signaling
pathways, the role of PKA has yet to be clarified (60). It is possible, however,
that the ROS induced by PKA activity may contribute to hypoxia-induced energy
failure.
In order to clarify the role of ROS in PC-12 cell death, WT and 123.7 cells
were pre-treated with the antioxidant N-acetyl cysteine (NAC) one hour prior to
their hypoxic exposure. N-acetyl cysteine treatment led to a drastic increase in
the ratio of reduced/oxidized forms of glutathione under both normoxic and
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hypoxic conditions. However, NAC treatment did not affect the total glutathione
levels in either cell line, suggesting that the antioxidant may be directly acting as
a reducing agent for the existing pool of glutathione, rather increasing generation
of new glutathione. Although the antioxidant function of NAC was previously
thought to be due solely to its role in glutathione biosynthesis, more recent work
suggests that NAC can also directly detoxify ROS (62, 63, 64).
Treatment of WT cells with NAC reduced ROS levels and improved cell
survival, indicating that oxidative stress contributes to hypoxia-induced PC-12
cell death. While preventing WT cell death, N-acetyl cysteine pre-treatment
failed to restore ATP levels, suggesting that energy depletion during hypoxia may
occur independently from oxidative stress. Alternatively, ROS production may be
a consequence of metabolic change, occurring downstream of these changes
and resulting in cell death. However, in chemical models of hypoxia, antioxidant
treatment was found in PC-12 cells to restore ATP levels following administration
of cyanide (65). Thus the effect of antioxidant treatment on energy depletion
may depend on the type and severity of hypoxic insult, or the antioxidant used.
Specific Aim 3 was to determine whether PKA affects cellular energetic
status through regulation of metabolic pathways. PKA has also been linked to
the control of the glycolytic rate limiting enzyme, phosphofructokinase,
implicating PKA in the regulation of glucose metabolism (35,36). HIF-1 a, a
hypoxia-regulated transcription factor, recognizes and binds the hypoxia
response element, activating transcription of a wide variety of genes. Among
these genes are also several glucose transporters and multiple glycolytic
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enzymes. Increased HIF-1 a dependent transcription may provide energy
resources allowing the cells to cope with the hypoxic stress. HIF-1 a protein
stability and its ability to bind DNA are controlled by phosphorylation and by
hydroxyprolination, and requires PKA-dependent transcription factors binding as
co-activators for transcriptional activation (6,37,38). Thus, in addition to its effects
on oxidative stress, PKA may modulate cellular survival to hypoxia through
regulation of metabolic pathways.
To determine whether mitochondrial function is differentially affected by
hypoxia in these two cell types, changes in mitochondrial membrane potential
were assessed using JC-1, a fluorescent probe sensitive to changes in
mitochondrial membrane potential. WT and 123.7 cells exhibited similar
mitochondrial membrane potentials under normoxic states and both cell types
showed a trend of decrease in JC-1 ratio upon hypoxic exposure. However,
overall mean normoxic and hypoxic JC-1 ratios were in higher in 123.7 cells than
in WT cells. These data may indicate that PKA has an inhibitory effect on
mitochondrial metabolism and contributes to the loss of mitochondrial membrane
potential. In cardiomyocytes, the addition of exogenous PKA cat-a leads to a
loss of the mitochondrial membrane potential (59).
However, in cardiomyocytes, the actions of PKA cat-a on mitochondrial
membrane potential were blocked by administration of an antioxidant (Nagasaki,
2007). Antioxidant treatment was also found in PC-12 cells to restore
mitochondrial membrane potential following cyanide treatment (65). In our
experimental conditions, antioxidant treatment had no effect on the mitochondrial
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membrane potential. Thus it appears that the mechanism by which PKA controls
mitochondrial function may differ according to the cell line and the extent and
type of hypoxic insult.
To further examine the effect of PKA activity on mitochondrial function, the
expression of cytochrome oxidase (COX IV) was examined. COX IV is the last
enzymatic complex in the mitochondrial electron transport chain. Hypoxia
decreases the V max of cytochrome oxidase, resulting in production of ROS due to
the improper flow of electrons and leakage of oxidant radically mainly at the
levels of Complexes I and III (14, 15). COX IV expression was significantly
higher in 123.7 cells relative to WT cells during both RA and SH, suggesting
either an increase in mitochondrial enzyme or in mitochondrial number with PKA
inactivation. As expected, COX IV expression was decreased upon hypoxic
exposure in both cell types. Antioxidant treatment had no effect on COX IV
expression in either cell type, indicating that ROS levels do not directly affect
COX IV expression in our experimental model.
COX IV activity may still be sufficient in 123.7 cells, despite the lower
oxygen levels, to allow the flow of electrons through the mitochondrial
complexes. Additionally, in the absence of PKA activity, downregulation of COX
IV activity by PKA phosphorylation may not occur. This could allow 123.7 cells to
maintain mitochondrial energy production even under drastically reduced oxygen
conditions, and increase their ability to maintain electron flow through the
mitochondrial transport chain without electron leakage and ROS production.

83

Maintenance of low levels of COX IV activity under hypoxic conditions has been
observed in hypoxia-tolerant model systems (66).
HIF-1 ex, whose stabilization is influenced by PKA-dependent transcription
factors, contributes to the shift from aerobic to anaerobic metabolism under
hypoxic states. Additionally, hypoxia-induced ROS production has been shown
to be necessary for stabilization of HIF-1 ex (67). In the PKA activity deficient
123.7 cell line, HIF-1 signaling may be depressed, leading to disruption of this
metabolic shift. This could explain the ability of 123.7 cells to maintain a low
level of aerobic metabolism under hypoxic conditions.
In normally functioning cells, as COX IV expression and/or activity
decreases under hypoxic conditions, cells must progressively rely on anaerobic
metabolism for energy production. Glucose is quickly used within the cell to
produce ATP via enhanced glycolytic activity. I have shown here that glucose
levels in the media do significantly drop upon hypoxic exposure in both cell types.
However, this decrease was much larger in the WT cells, which had negligible
levels of extracellular glucose following 24h of hypoxic exposure. The 123.7 cells
had higher levels of extracellular glucose at both RA and SH, indicating a lower
glycolytic flux. This further indicates that PKA activity facilitates the hypoxiainduced metabolic shift from aerobic to anaerobic metabolism. The 123.7 cells
appear to continue aerobic metabolism for a longer period of time than WT cells
under hypoxic stress, allowing for more efficient ATP production, and potentially
protecting them from hypoxia-induced cell death.
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WT and 123.7 cells had a drop in extracellular pH following hypoxic
exposure, which is likely due to the efflux of lactate from the cell and/or the
release of acidic cellular contents. Intracellular acidification may upregulate
activity of the Na +/H+ exchanger, but this process is likely limited by the
accumulation of extracellular lactate surrounding the membrane (58). It has
been shown in sheep purkinje fibers that inhibition of the Na +/H+ exchanger had
no significant effect on extracellular acidification following hypoxic exposure (58).
Hypoxia-induced decreases in pH were not affected by N-acetyl cysteine
treatment, despite the fact that antioxidant treatment rescues WT cells. This
suggests that hypoxia-induced decreases in extracellular pH may be primarily
due to the release of lactate rather than from the release of acidic content from
dying cells.
Indeed, extracellular lactate levels did increase in both WT and 123.7 cells
after hypoxic exposure. WT cells, however, exhibited higher levels of lactate
release under both normoxic and hypoxic conditions, in accordance with their
increased glucose utilization, indicating that PKA activity enhances the
production and/or release of lactate from cells. Additionally, WT cells exhibited
higher extracellular pyruvate levels under normoxic conditions, but were
unaffected by hypoxic exposure. The 123.7 cells displayed an increase in
extracellular pyruvate upon hypoxic challenge. PKA has been shown to be
necessary for the stabilization of lactate dehydrogenase mRNA (68). This
complete inactivation of PKA activity in 123.7 cells may prevent the efficient
conversion of lactate to pyruvate.
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PKA could upregulate glycolytic flux during hypoxia directly through
enzymatic control, or indirectly due to the production of oxidant species.
However, antioxidant treatment with N-acetyl cysteine had no effect on
extracellular glucose values, suggesting that ROS do not contribute to
upregulation of glycolytic flux under hypoxic conditions. Furthermore, treatment
with N-acetyl cysteine did not affect lactate or pyruvate values, once again
indicating that oxidative stress does not alter glycolytic rate. Thus, the effect of
PKA on glycolytic flux appears to occur directly through regulation of enzymatic
activity, rather than ROS production.
The PKA signaling pathway plays many vital roles in the cell. The majority
of knockout mice containing a null mutation in the PKA catalytic a subunit
experience early postnatal lethality (69). Those mice that do survive have
upregulation of the PKA catalytic

p subunit (69).

Since PKA activity is minimal in

the 123.7 PC-12 cell line, compensations may have occurred in order for them to
remain viable. For Specific Aim 4, I wanted to determine whether restoration of
PKA activity in the 123.7 cells would abrogate differences in hypoxic
susceptibility and energy homeostasis between WT and 123.7 cells. The 123.7
cells were transfected with plasmids encoding active PKA catalytic a subunits to
restore PKA activity in these cells. Over-expression of PKA cat a was verified by
Western blotting and PKA activity assays.
Transfection of 123.7 cells with an active catalytic a subunit of PKA
increased ROS levels upon hypoxic exposure, albeit to a level less than that
seen in WT cells. This finding confirms that PKA activity is necessary for the

86

onset of oxidative stress under hypoxic conditions in our experimental model.
However, the oxidative stress in transfected 123.7 cells did not appear to be
significant enough to cause hypoxic cell death. This finding indicates that
oxidative stress may lead to cell death in a dose-dependent manner, and that
PKA transfection in 123.7 cells did not reach a threshold of oxidative stress
necessary for induction of death.
Furthermore, transfection of 123.7 cells with an active catalytic subunit of
PKA did not appear to affect metabolic variables such as extracellular pH,
glucose, lactate, or pyruvate levels. Similarly, intracellular ATP levels were not
significantly altered relative to empty vector controls. This indicates that transient
transfection of PKA cat a into 123.7 cells may not be sufficient to induce
upregulation and maintenance of the high metabolic rate seen in WT cells.
Conversely, metabolic adaptations may have occurred in 123.7 cells following
prolonged PKA inactivation that may prevent efficient upregulation of metabolic
processes following re-activation of the pathway.
In conclusion, the experiments which I have performed support my original
hypothesis that PKA activity regulates PC-12 hypoxic cell death via oxidative
stress (Figure 45). PKA activity appears to contribute to hypoxia-induced cell
death via enhanced production of ROS, but does not appear to playa role in the
regulation of cellular antioxidant mechanisms. The role of PKA in hypoxiainduced oxidative stress was confirmed through transfection studies in which
restoration of PKA activity in the 123.7 cells increased their production of ROS.
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Hypoxia also leads to a decrease in mitochondrial potential, COX IV
expression, and ATP levels, all of which appear to be PKA-activity dependent.
On the other hand, PKA activity increases glycolytic flux in PC-12 cells,
particularly under periods of hypoxia. PKA thus appears to affect cellular
energetic status through regulation of metabolic pathways. However, I was
unable to confirm the role of PKA in these processes through the transfection
studies. Prolonged PKA activation may be necessary for upregulation of
metabolism to the levels seen in WT cells. Alternatively, a more sustained
increase in ROS levels may trigger metabolic responses which are induced by
HIF-1 a or NF-KB transcriptional activation (43).
This work dictates a need for further examination into the role of PKA in
the hypoxic response, and identification of cellular targets that could be used to
disrupt the deleterious effects of PKA under hypoxic states. Modulation of the
PKA signaling pathway could thus be used as a novel therapeutic strategy to
improve cellular adaptation and recovery in the many pathologies characterized
by periods of hypoxia.
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Figure 45: The Role of Protein Kinase A in Hypoxia-Induced PC-12
Cell Death I have confirmed that the PKA signaling pathway
contributes to hypoxia-induced PC-12 cell death through the production
of reactive oxygen species. It was also shown that oxidative stress
contributes to cell death independently of energy depletion in PC-12
cells. I was unable to confirm, however, the role of PKA in hypoxiainduced energy depletion and the contribution of energy failure to cell
death.
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